{"pageContent": "Background: Patients with disabilities represent a unique minority population. The incidence of prostate-specific antigen (PSA) testing among this population is unknown.", "metaData": {"source": "Prostate cancer: should potency be preserved by deferring hormonal treatment in patients with asymptomatic metastatic disease?\nhttps://pubmed.ncbi.nlm.nih.gov/1924467/"}}